The Complexities of Lyme Disease and Alpha-Gal Syndrome
# Introduction
Speaker: Dr. Tiffany Leonard
Topic: Complexities of Lyme disease and Alpha-gal syndrome.
Audience engagement: Possible lack of familiarity with Alpha-gal.
Note on visual content: AI assistance used in creating visually appealing slides, not in content.
Learning Objectives
Identify the four Borrelia species causing Lyme disease and detail clinical differences.
Describe the science behind post-treatment Lyme disease syndrome (PTLDS) and chronic Lyme disease.
Identify evidence-based treatment options for Lyme disease and PTLDS.
Identify ingredients and common medicines and foods causing reactions in Alpha-gal syndrome.
Slides available for download, extra slides on other tick-borne diseases included.
Tick Information
Tick Species in the U.S.
Approximately a dozen tick species causing disease.
Focus on three specific species:
Ixodes scapularis (common black-legged tick) - spreader of Lyme disease.
Ixodes pacificus (western black-legged tick) - also spreads Lyme disease.
Amblyomma americanum (lone star tick) - associated with Alpha-gal syndrome.
Tick Habitats
Prefer dense woodland underbrush, humid environments, tall grasses, and transition zones between trails and nature.
Humidity is crucial for tick presence; central U.S. has lower incidences compared to Northeast and Southern US.
Geographic Distribution
Ixodes scapularis is primarily found in:
Northeast U.S.
Expanding westward and southward due to climate change.
Amblyomma americanum is prevalent in:
Southeast and South Central U.S.; moving northward.
Ixodes pacificus found in:
California, Western Oregon, Washington; sporadic in Utah and Arizona.
Climate and Tick Movement
Climate warming, wildlife movement, land use changes, and urban development drive tick migration.
Increased tick presence even in urban areas like Philadelphia.
Tick-Borne Diseases Prevalence
Lyme disease cases (2023): approximately 90,000, significantly more than second-most prevalent disease, babesiosis (16.5 cases).
New entities like STARI and Alpha-gal are not commonly tracked; limited data.
Tick Life Cycle
Life cycle of ticks like Ixodes species:
Spring: Eggs hatch into larvae, feed on small animals (potential Lyme disease acquisition).
Fall: Larvae feed on larger mammals and spread Lyme.
Winter: Hibernate; infestation occurs in nymph form the following spring.
Adult stage: Mostly feed on large mammals but less effective at spreading disease.
Lyme Disease Overview
Common Hosts
Most common hosts for Lyme disease:
Eastern U.S.: White-footed mouse (not white-tailed deer).
Western U.S.: Gray squirrel.
Western fence lizard: Not susceptible to Lyme; can eliminate Lyme bacteria if bitten.
Historical Context
First identified in 1970s in Lyme, Connecticut due to unusual arthritis in children.
Bacterial cause identified in 1981 as Borrelia burgdorferi; named in 1982.
Differences in species now characterized as:
Borrelia burgdorferi sensu stricto (SS) - original strain.
Borrelia burgdorferi sensu lato (SL) - related species (12 known to cause various diseases).
Noteworthy Species
Borrelia mayonii identified in 2013 by the Mayo Clinic, creating additional Lyme disease presentations.
In Europe: Borrelia afzelii, Borrelia garinii, and Borrelia bissettii (associated with various diseases).
Detection and Management of Lyme Disease
Symptoms of Lyme Disease
Early localized: Erythema migrans rash (bull's eye, not most common), fever, chills, fatigue, myalgias.
Early disseminated: Multiple rashes, neurological symptoms, including facial palsies like Bell's Palsy.
Late disseminated: Severe arthritis, neuroborreliosis, persistent brain fog, and post-treatment Lyme disease syndrome (PTLDS).
Post-treatment Lyme disease syndrome: Ongoing symptoms after treatment, thought to involve immune dysregulation.
Diagnostic Techniques
Two-tiered testing approach: ELISA and Western blot. Limitations include high false-negative rates particularly within the first six weeks of infection.
Diagnosis often based clinically on symptoms rather than testing; tests are more reliable in later stages.
Culture is ineffective for Borrelia due to growth requirements.
Treatment Options
Early Lyme Disease
Firstline treatment:
Doxycycline 100 mg twice daily for 10-14 days.
Alternatives: Cefuroxime, Amoxicillin, and Azithromycin.
Neuroborreliosis
Oral doxycycline if mild symptoms; otherwise, consider IV treatments such as ceftriaxone.
Cardiac Lyme Disease
Mild cases: Oral doxycycline. Severe or symptomatic cases may require IV ceftriaxone.
Lyme-associated Arthritis
Minimum 4 weeks doxycycline, need for further treatment if no improvement.
Concerns with Treatment
Significant danger with overuse of prolonged antibiotics without clear evidence.
Prevention and Prophylaxis
Prophylactic treatment with doxycycline within 72 hours of known exposure in endemic areas.
Not effective if tick is brown-legged (non-Ixodes).
Alpha-Gal Syndrome Overview
Discovery
Identified post-tick bites in 2002 in the U.S.; related reactions also noted in Australia.
Cross-reactivity with cetuximab; 7 states made Alpha-gal reportable by 2018.
Cases rising globally; significant increase in pediatric cases (15% annually).
Symptoms and Diagnosis
Delayed response (15 minutes to 3 days) to exposure after consuming mammal products.
Diagnosis: IgE testing for Alpha-gal antibodies; careful patient history required.
Common Foods to Avoid
Mammal products: beef, pork, lamb, venison, rabbit; consider dairy carefully.
Hidden mammal derivatives: gelatin, glycerin, magnesium stearate.
Potential Management
Carry an EpiPen; careful re-introduction of suspected food products; consider acupuncture.
Prevention Strategies for Lyme and Alpha-Gal Syndrome
Preventive measures against ticks include:
Use of DEET, permethrin, and other repellents.
Avoid tall grass, keep yards maintained, and do frequent tick checks on the body.
Educating patients about tick species and reactions. Consider outdoor exposure risk.
Conclusion
Encouragement for patient education on Lyme disease and Alpha-gal syndrome; promoting tick awareness and prevention measures. Audience encouraged to contact Dr. Tiffany Leonard directly for questions.
References
Dr. Tiffany Leonard's extensive research and knowledge, supported by numerous references provided in the slides.